The EU Joint Programme – Neurodegenerative Disease Research (JPND) will shortly launch a new cohesive action with the European Commission – a call for “Multinational research projects on Personalised Medicine for Neurodegenerative Diseases”. More than €30 million have already been earmarked by JPND member countries and the European Commission for this action.
Neurodegenerative diseases are debilitating and still largely untreatable conditions. They are characterised by a large variability in their origins, mechanisms and clinical expression. When searching for a medical solution, e.g. a treatment or an optimised approach for care, this large variability constitutes a major hurdle if not controlled. Indeed a treatment addressing one disease pathway may not be useful for all patients experiencing the relevant symptoms. Thus, one of the greatest challenges for treating neurodegenerative diseases is the deciphering of this variability.
JPND has chosen to focus in the area of Precision Medicine, which relates to the targeting of specific elements responsible for pathology in a given individual at a particular point in time. It is an emerging approach for disease prevention, diagnosis and treatment that takes into account individual variability in genes, biological/molecular characteristics together with environmental and lifestyle factors.
Registration of application in E-grant for Danish partners
All Danish partners in International Project applications under IFD must register in our online administration platform E-grant. The deadline for the registration is two weeks after the deadline for submitting the project application. Register under the same call option as you have applied. Name your project [Application ID – Acronym – Institution/Company]. Read more about how to register.
General Terms and Conditions for International Projects
IFD investment is given in accordance with The General Terms and Conditions for International Projects. The Terms and Conditions and Guidelines for Grand Solutions apply for all issues not mentioned in the present document.
Få de seneste nyheder om fondens aktiviteter.